…re clinical trials.Acknowledgements This research was funded by Vera Bradley Foundation and Brown Center for Immunotherapy, Indiana University.…
All extracted funders
Showing 781–840 of 3,238, ordered by supporting articles. Choose a funder to see its evidence.
Articles mentioning funders
5,089 articles · page 328 of 425…roval This study was approved by Dana Farber Cancer Institute’s Ethics Board; approval numbers 11-181 and 23-692.Abstract 35 Table 1Table su…
…r 2024;12:A490-A490.Ethics Approval ‘This study was approved by Australian Red Cross for the isolation of human Vδ1+ γδ T cells from healthy donors’…
…Mar;27(3):419–25.Ethics Approval This study was approved by the WCG IRB; approval number CINJ 192204.…
…he Mass General Cancer Center Tumor Cartography Center, and the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation.References Sade-Feldman M, et al. Defining T cell states associ…
… a phase II trial focused on efficacy, to be conducted with the PragmaTIL network.Trial Registration Clinical TrialsGov: NCT05869539Ethics Approv…
…matol.2019.10.006Ethics Approval This study was approved by the Mass General Brigham IRB, under Protocol #: 2020P002307.Consent Written informed consent…
…ng evaluated in a clinical trial for treatment of solid tumors (NCT06598371). Here, we interrogated the impact of SOCS1 and Regnase-1 inact…
…ts This work was supported by preclinical research funding from Turnstone Biologics.References Kristensen NP, Heeke C, Tvingsholm SA, et al. Neoant…
…s.gov, trial number NCT02858310. This study was approved by the NIH IRB; approval number 16C0154.References Robbins PF, Kassim SH, Tran…
…wledgements M.T. M.B. and M.M.T. acknowledges support from the ‘Associazione Italiana per la Ricerca sul Cancro’ (grant no. MFAG 2021—ID. 26339 to M.T.). All of the other auth…
… database spanned from 2011 (first authorization of ICIs by the FDA) to May 2025. Inclusion criteria included patients diagnosed wi…